Model Based Drug Development
May 27, 2011 at the Royal Institute of Technology (KTH), Stockholm
It is a great pleasure to present an upcoming 1 day conference jointly organized by Statisticians in Finnish Pharmaceutical Industry (SSL), Swedish Society of Medical Statistics (FMS) and the Center for Industrial and Applied Mathematics (CIAM) at the Royal Institute of Technology (KTH).
The conference theme is “Model Based Drug Development” in a broad sense, covering modelling of relevance for clinical development from early to late phase.
Confirmed speakers and provisional titles:
Alun Bedding, GlaxoSmithKline -Model Based Adaptive Designs in Dose Finding including case studies
Jouni Kerman, Novartis Pharma -Bayesian modeling in clinical trials: from Early Development to Phase III.
Jukka Corander, University of Helsinki: Bayesian prediction of protein-ligand interactions
Stig-Johan Wiklund, AstraZeneca - Modeling to evaluate drug development strategies
Tobias Rydén, KTH - Hidden Markov models and disease dynamics
Andrew Hooker, BMC Uppsala University- Model-based clinical trial optimization in
disease progression studies
The detailed final program will shortly be presented on the conference homepage.
Venue: The Royal Institute of Technology (KTH), Stockholm
Conference language: English
Registration:
Sweden: send an e-mail to [log in to unmask] and transfer the registration fee 450 SEK to FMS´s plusgiro 4350474-5.
Finland: send an e-mail to [log in to unmask] and transfer the registration fee 50 € to SSL´s bank account 571113-225692.
International: contact [log in to unmask] for details.
The fee includes lunch and breaks with beverages and snacks.
Last day for registration is Friday May 13.
For more details see this link
http://www.kth.se/sci/centra/ciam/calendar/events/ciam-fms-ssl-joint-workshop-on-model-based-drug-development-1.80896?date=2011-05-27&orgdate=2011-03-01&length=1&orglength=31
You may leave the list at any time by sending the command
SIGNOFF allstat
to [log in to unmask], leaving the subject line blank.
|